Antidiabetic Potential of Novel 1,3,5-Trisubstituted-2-Thioxoimidazloidin-4-One Analogues: Insights into α-Glucosidase, α-Amylase, and Antioxidant Activities

• Váldodahkkit: Salma M. Khirallah (Dahkki), Heba M. M. Ramadan (Dahkki), Hossam Aladl Aladl Aladl (Dahkki), Najla O. Ayaz (Dahkki), Lina A. F. Kurdi (Dahkki), Mariusz Jaremko (Dahkki), Samar Zuhair Alshawwa (Dahkki), Essa M. Saied (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: MDPI AG, 2022-12-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

As the ninth leading cause of death globally, diabetes mellitus (DM) is considered to be the worst chronic metabolic disease requiring an enormous need for healthcare with over 578 million expected cases by 2023. Several recent findings have demonstrated that mediating the activity of carbohydrate-h...